Cite
Response to: "Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate".
MLA
Moo, Tracy-Ann, and Monica Morrow. “Response to: ‘Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate.’” Annals of Surgical Oncology, vol. 27, no. Suppl 3, Dec. 2020, p. 918. EBSCOhost, https://doi.org/10.1245/s10434-020-08264-5.
APA
Moo, T.-A., & Morrow, M. (2020). Response to: “Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate.” Annals of Surgical Oncology, 27(Suppl 3), 918. https://doi.org/10.1245/s10434-020-08264-5
Chicago
Moo, Tracy-Ann, and Monica Morrow. 2020. “Response to: ‘Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate.’” Annals of Surgical Oncology 27 (Suppl 3): 918. doi:10.1245/s10434-020-08264-5.